Bronchial Neoplasms

Small/Middle Tier Cities and County Lung Cancer Quality Improvement Project (QIP) Study

Osimertinib With Chemotherapy as First-line Therapy for EGFR Mutation-positive NSCLC

Evaluation of a New Open Source Virtual Bronchoscope Navigation System

Phase 1/2 Study of the Highly-selective RET Inhibitor, Pralsetinib (BLU-667), in Participants With Thyroid Cancer, Non-Small Cell Lung Cancer, and Other Advanced Solid Tumors

(Concerto) Study of BLU-451 in Advanced Cancers With EGFR Exon 20 Insertion Mutations

(SYMPHONY) Phase 1/2 Study Targeting EGFR Resistance Mechanisms in NSCLC

Icotinib for Completed Resected IB NSCLC With EGFR Mutation

Cryotechnique as a Diagnostic and Therapeutic Tool of Endobronchial Tumors

EGF816 and Trametinib in Patients With Non-small Cell Lung Cancer Harboring Activating EGFR Mutations

Navigated EBUS and Functional Imaging in Lung Cancer

A Phase Ⅱ Clinical Study of Adebrelimab Combined With Chemotherapy and Concurrent Radiotherapy for Extensive-Stage Oligometastatic SCLC

A Home-Based Approach Study to Evaluate the Efficacy and Safety of Alectinib in Locally-Advanced or Metastatic ALK-Positive Solid Tumors

(HARMONY) Study of BLU-701 in EGFR-mutant NSCLC

Cardiac Safety Study of Entinostat in Men and Women With Advanced Solid Tumors

Continuation Study of Entinostat in Combination With Pembrolizumab in Patients With Advanced Solid Tumors

The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial

ThoHSpEkt Thoracoscopic Ectomy of Radioactively Marked Pulmonary Nodules With Free-hand SPECT

Dynamic Changes of Circulating Tumor DNA in Late Stage NSCLC Patients

Automatic CT-to-patient Registration During Navigated Bronchoscopy and EBUS

Study of the Fixation of Various Vectors in PET/CT in Patients With a With Lung Cancer Before and During of CRT or RT